Year All20242023202220212020201920182017201620152014 Sep 15, 2017 Soleno Therapeutics Presents Updated Safety and Efficacy Data from Clinical Trial of DCCR for Treatment of Prader-Willi Syndrome Sep 13, 2017 Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR in Treatment of Prader-Willi Syndrome Sep 05, 2017 Soleno Therapeutics Announces CFO Transition Aug 11, 2017 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results Jul 24, 2017 Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc. Jul 05, 2017 Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome May 11, 2017 Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results Mar 15, 2017 Capnia Reports Fourth Quarter and Full Year 2016 Financial Results Mar 08, 2017 Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company Feb 07, 2017 Capnia to Present at the 19th Annual BIO CEO & Investor Conference
Sep 15, 2017 Soleno Therapeutics Presents Updated Safety and Efficacy Data from Clinical Trial of DCCR for Treatment of Prader-Willi Syndrome
Sep 13, 2017 Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR in Treatment of Prader-Willi Syndrome
Aug 11, 2017 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Jul 05, 2017 Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome